Scissortail Wealth Management, LLC Halozyme Therapeutics, Inc. Transaction History

Scissortail Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$32.86 - $55.7 $95,951 - $162,644	2,920 New	2,920 $111,000
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $121,574 - $157,216	3,255 New	3,255 $131,000
Q1 2022 Aug 19, 2022	SELL	$31.97 - $41.06 $104,062 - $133,650	-3,255 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$31.82 - $40.75 $103,574 - $132,641	3,255 New	3,255 $131,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Scissortail Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Scissortail Wealth Management, LLC with notifications on news.